CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $223,551 | +251080.9% | 21,454 | +45.3% | 0.00% | +50.0% |
| Q4 2022 | $89 | -100.0% | 14,762 | -33.9% | 0.00% | -75.0% |
| Q2 2022 | $304,000 | +22.1% | 22,335 | +75.8% | 0.01% | +33.3% |
| Q1 2022 | $249,000 | -21.9% | 12,707 | +36.5% | 0.01% | +20.0% |
| Q4 2021 | $319,000 | +46.3% | 9,307 | +213.2% | 0.01% | +25.0% |
| Q2 2021 | $218,000 | -21.3% | 2,972 | -1.9% | 0.00% | -33.3% |
| Q1 2021 | $277,000 | – | 3,031 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |